Related Experiment Video
Updated: Jun 1, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
Relationship between angiotensin II receptor expression and cardiovascular risk factors in Mexican patients with
Manuel Baños1, Monica G Arellano-Mendoza, Hilda Vargas-Robles
1Department of Molecular Biomedicine, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional México City, C.P. 07360, Mexico.
Abstract:
The density of Angiotensin II (Ang) receptors on tissue surfaces is regulated by multiple hormones, cytokines and metabolic factors and is profoundly affected by various pathological conditions, such as age, diet and environmental conditions. The participation of several cardiovascular risk factors in the regulation of Angiotensin II receptor expression has been incompletely studied. We performed an ex-vivo study with human aortic postsurgical specimens to test the hypothesis that Ang AT1 and AT2 receptor expression in human aortic arteries is associated with the presence of cardiovascular risk factors. We included 31 Mexican patients with coronary artery disease. We evaluated Angiotensin II receptor expression by immunostaining and angiotensin converting enzyme insertion/deletion (ACE I/D) polymorphisms by polymerase chain reaction. AT1 and AT2 receptor expression was increased in the aortic segments from the cardiovascular patients compared with control arteries and in patients with the DD genotype. There was a correlation between increased AT1 receptor expression and the number of cardiovascular risk factors present in the patient. Furthermore, reduction of AT1 expression correlated with the number of drug combinations used in the patients. These correlations were not present with respect to AT2 receptor expression. We suggest that increased AT1 receptor expression is associated with the DD genotype. Thus the presence of several cardiovascular risk factors as well as DD genotype, induce AT1 expression increasing the probability to develop coronary occlusive disease.
Insights
Cardiovascular risk factors and the ACE I/D DD genotype increase Angiotensin II AT1 receptor expression in the aorta. This heightened expression is linked to coronary artery disease development.
Area of Science:
- Cardiovascular Medicine
- Molecular Biology
- Genetics
Background:
- Angiotensin II (Ang) receptor density is influenced by various factors and pathological conditions.
- The role of cardiovascular risk factors in regulating Angiotensin II receptor expression is not fully understood.
Purpose of the Study:
- To investigate the association between cardiovascular risk factors and Angiotensin II AT1 and AT2 receptor expression in human aortic arteries.
- To explore the link between ACE I/D genotype and Angiotensin II receptor expression.
Main Methods:
- Ex-vivo study using human aortic postsurgical specimens from 31 Mexican patients with coronary artery disease.
- Immunostaining to evaluate Angiotensin II receptor expression.
- Polymerase chain reaction to determine angiotensin converting enzyme insertion/deletion (ACE I/D) polymorphisms.
Main Results:
- Both AT1 and AT2 receptor expression were elevated in aortic segments of cardiovascular patients compared to controls.
- Patients with the DD genotype showed increased AT1 and AT2 receptor expression.
- Increased AT1 receptor expression correlated with the number of cardiovascular risk factors and decreased with drug combinations.
- No such correlations were observed for AT2 receptor expression.
Conclusions:
- Increased AT1 receptor expression is associated with the DD genotype and the presence of cardiovascular risk factors.
- Elevated AT1 receptor expression may contribute to the development of coronary occlusive disease.
Related Concept Videos
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Coronary Artery Disease II: Pathophysiology
Hypertension II: Pathophysiology
Coronary Artery Disease I: Introduction
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
